过敏免疫疗法市场规模预计在 2021 年为 21.6 亿美元,2023 年为 xx 亿美元。预计到 2031 年将达到 51.1 亿美元,到 2031 年的复合年增长率为 9.0%。新给药方法的开发、联合疗法的兴起、个性化医疗的进步可能仍是过敏免疫疗法市场的主要趋势。
过敏免疫疗法市场分析
全球范围内过敏性疾病的患病率不断上升,预计将推动过敏免疫疗法市场的增长。过敏性疾病的患病率不断上升,需要过敏免疫疗法,这是一种安全有效的治疗方法,可针对昆虫霉菌、花粉和动物等过敏原以及过敏性哮喘。根据美国过敏、哮喘和免疫学学院的数据,2021 年,美国三分之一的成年人和四分之一以上的儿童报告患有季节性过敏、湿疹或食物过敏。
全球范围内过敏症的日益流行增加了全球对免疫疗法的需求,这有利于市场的增长。
过敏免疫疗法市场概览
全球过敏免疫疗法市场按地区划分为北美、欧洲、亚太、中东和非洲以及南美和中美。由于过敏性疾病的患病率不断上升以及舌下剂型的技术进步等因素,预计该地区的市场将出现增长。然而,预测期内,过敏免疫疗法的使用缺陷和各地区监管差异可能会阻碍市场增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
过敏免疫疗法市场:
复合年增长率(2023 - 2031)9.0%- 2021 年市场规模
21.6 亿美元 - 2031 年市场规模
51.1 亿美元
市场动态
- 过敏性疾病患病率不断上升
- 拥有强大的产品线
- 提高 FDA 药品批准数量
关键人物;主力;重要一员
- ALK-Abelló A/S
- 雀巢健康科学
- 莱蒂制药
- 斯塔勒根斯·格里尔
- HAL 过敏 BV
- 强生服务公司
- 安尼吉斯
- DBV 技术
- Dermapharm 控股
- 过敏治疗
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 皮下免疫治疗
- 过敏性鼻炎
- 哮喘
- 食物过敏
- 毒液过敏
- 其他的
- 医院药房
- 零售药店
- 网上药店
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
过敏免疫疗法市场驱动因素和机遇
人们对过敏治疗认识的不断提高可能会有利于市场。
公众对过敏症及其治疗方案的认识不断提高,这推动了对更好治疗方法的需求。人们寻求缓解可能严重影响其生活质量的症状。
州教育总监办公室 (OSSE) 和健康与保健司将于 2023 年 5 月 14 日至 5 月 20 日庆祝食物过敏宣传周。该活动的重点是教育和提高对食物过敏和过敏反应的认识。
拥有强大的产品线——过敏免疫疗法市场的机会
过敏免疫疗法产品线包括 15 种处于不同临床开发阶段的疗法。参与过敏性疾病免疫疗法开发的一些参与者包括 Aimmune Therapeutics Inc.、DBV Technologies SA、Genentech Inc.、ASIT biotech SA、Inmunotek SL、Anergis SA、Biomay AG 和 Regeneron Pharmaceuticals Inc.
正在进行临床试验的各种免疫疗法的积极临床结果支持开发基于过敏免疫疗法的药物。例如,2022 年 11 月,美国食品药品监督管理局 (FDA) 授予 Alladapt Immunotherapeutic 公司的 ADP101 快速通道资格,这是一种用于治疗一种或多种最主要的食物过敏原的试验性口服免疫疗法
过敏免疫疗法市场报告细分分析
促成过敏免疫疗法市场分析的关键部分是服务和应用。
- 根据治疗方法,过敏免疫疗法市场分为皮下免疫疗法 (SCIT) 和舌下免疫疗法 (SLIT)。2023 年,皮下免疫疗法 (SCIT) 部分占据了最大的市场份额。此外,舌下免疫疗法 (SLIT) 部分预计将在预测期内以最快的速度增长。
- 根据过敏类型,过敏免疫疗法市场分为过敏性鼻炎、哮喘、食物过敏、毒液过敏等。过敏性鼻炎部分在 2023 年占据了最大的市场份额,预计同一部分在预测期内将在市场上实现最高的复合年增长率。
- 过敏免疫疗法市场按分销渠道细分为医院药房、零售药房和在线药房。2023 年,医院药房设置部分按分销渠道占据了最大的市场份额。此外,预计同一细分市场在预测期内增长最快。
过敏免疫疗法市场份额(按地区)分析
过敏免疫疗法市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美/南美和中美。
北美包括美国、加拿大和墨西哥。北美在过敏免疫疗法市场占有最大份额,其中美国占有最大市场份额,其次是加拿大。美国在过敏免疫疗法市场占有最大份额,这归因于过敏性疾病的日益流行,从而增加了对过敏免疫疗法的需求并推动了市场的增长。此外,它是许多从事过敏免疫疗法制造的制造商的总部,进一步推动了该国市场的增长。此外,消费者对过敏治疗的认识不断提高,增加了北美对健康补充氧气的需求。
亚太地区预计将成为所有其他地区中增长最快的地区。由于澳大利亚、印度等国家过敏和免疫疾病的发病率高等因素,亚太地区市场的增长预计将以更快的速度增长。此外,政府在预防和治疗策略方面采取的举措越来越多,预计将为该地区提供有利可图的市场增长前景。此外,在预测期内,发展医疗保健基础设施和增加投资以促进研究活动预计将推动亚太过敏免疫疗法市场的发展。
过敏免疫疗法市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 21.6亿美元 |
2031 年市场规模 | 51.1亿美元 |
全球复合年增长率(2023 - 2031) | 9.0% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按治疗
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
过敏免疫疗法市场新闻和最新发展
过敏免疫疗法市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是过敏免疫疗法和策略市场的发展列表:
- 2020 年 8 月,雀巢健康科学收购了 Aimmune Therapeutics。Aimmune 获批的 Palforzia 疗法将扩大雀巢健康科学的产品组合,成为首个也是唯一一个获得 FDA 批准的疗法,有助于降低儿童对花生过敏反应的频率和严重程度。(来源:公司新闻稿)
- 2023 年 9 月,Stallergenes Greer 与雀巢健康科学达成协议,利用花生过敏口服免疫疗法 Palforzia。(来源:公司新闻稿)
过敏免疫疗法市场报告覆盖范围和交付成果
“过敏免疫疗法市场规模和预测(2021-2031)”报告对市场进行了详细分析,涵盖以下领域:
- 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
- 详细的公司简介
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.